Pharmabiz49m
Quest Diagnostics introduces specimen self-collection for common GTIs testing at nationwide network of patient service centres
Secaucus, New Jersey Thursday, October 17, 2024, 14:00 Hrs [IST] ...
Pharmabiz1h
L V Prasad Eye Institute founder highlights creation of infrastructure for corneal transplants in India
L V Prasad Eye Institute founder highlights creation of infrastructure for corneal transplants in India: Our Bureau, Bengaluru Thursday, October 17, 2024, 13:30 Hrs [IST] Dr Gulla ...
Pharmabiz1h
Vaxart to present norovirus data at IDWeek 2024 underscoring commitment to address significant unmet need
Vaxart to present norovirus data at IDWeek 2024 underscoring commitment to address significant unmet need: South San Francisco, California Thursday, October 17, 2024, 13:00 Hrs [I ...
Pharmabiz2h
Micro Labs acquires Swipha, to strengthen its presence in Nigeria, Africa
Micro Labs acquires Swipha, to strengthen its presence in Nigeria, Africa: Our Bureau, Bengaluru Thursday, October 17, 2024, 12:45 Hrs [IST] Micro Labs, Karnataka’s pharma major ...
Pharmabiz2h
NIH & US FDA leaders call for innovation in development of smoking cessation treatments
NIH & US FDA leaders call for innovation in development of smoking cessation treatments: Bethesda, Maryland Thursday, October 17, 2024, 12:00 Hrs [IST] In a new commentary in the ...
Pharmabiz3h
Hoth Therapeutics receives US patent for its pioneering Alzheimer's treatment, HT-ALZ
Hoth Therapeutics receives US patent for its pioneering Alzheimer's treatment, HT-ALZ: New York Thursday, October 17, 2024, 11:00 Hrs [IST] Hoth Therapeutics, Inc., a clinical-sta ...
Pharmabiz4h
Merck’s STRIDE-8 phase 3 trial of Capvaxive demonstrates positive immune responses in adults with increased risk for pneumococcal disease
Merck’s STRIDE-8 phase 3 trial of Capvaxive demonstrates positive immune responses in adults with increased risk for pneumococcal disease: Rahway, New Jersey Thursday, October 1 ...
Pharmabiz5h
US FDA accepts for priority review GSK’s NDA for gepotidacin to treat uncomplicated urinary tract infections in female adults and adolescents
US FDA accepts for priority review GSK’s NDA for gepotidacin to treat uncomplicated urinary tract infections in female adults and adolescents: London, UK Thursday, October 17, 2 ...
Pharmabiz6h
Indian pharma & nutra sectors opt for LipoDuo technology to enhance stability & bioavailability factors
Indian pharma & nutra sectors opt for LipoDuo technology to enhance stability & bioavailability factors: Nandita Vijayasimha, Bengaluru Thursday, October 17, 2024, 08:00 Hrs [IST] ...
Pharmabiz6h
NABH introduces first-ever Care Home Accreditation Standards to improve quality & safety in home care
NABH introduces first-ever Care Home Accreditation Standards to improve quality & safety in home care: Shardul Nautiyal, Mumbai Thursday, October 17, 2024, 08:00 Hrs [IST] In a la ...
Pharmabiz6h
DoP directs NPPA to recalculate ceiling prices of three antibiotics based on Cipla's applications
DoP directs NPPA to recalculate ceiling prices of three antibiotics based on Cipla's applications: Gireesh Babu, New Delhi Thursday, October 17, 2024, 08:00 Hrs [IST] The Departme ...
Pharmabiz6h
NABH announces certification programme for HIS/EMR Systems
The National Accreditation Board for Hospitals and Healthcare Providers (NABH) has introduced a new certification programme for Hospital Information Systems (HIS) and Electronic Medical Records (EMR) ...